Unexpectedly, despite the influence of MDSC-derived SPARC on EMT markers and immune suppression, the tumor volume of SN25ASP tumors injected in WT and Sparc −/− mice was similar at the end, although the differed kinetics of growth that was initially faster in WT mice. The gene discussed is SPARC; the disease is neoplasm.